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MILES and Pirie (1939a) described a soluble antigen prepared from Brucella
melitensis. In its most highly aggregated form it appeared to be a complex of
at least two phospholipides with a protein-like material and the N-formyl deri-
vative of a polyhydroxyamine. Mention was made (Miles and Pirie, 1939a, b)
of a similar material obtained from Br. abortus, but the behaviour of this antigen
was at that time irregular and no details of its preparation and properties were
given. The differences that were observed in the biological behaviour of the
melitensis antigen (Miles and Pirie, 1939c) in different states of aggregation, taken
in conjunction with the general body of immunological experience, suggested
that the relative inefficiency, as immunizing agents, of preparations made from
Br. abortus by other workers, might be due to the fact that the antigens in them
were not in the optimum state of aggregation. Working on this hypothesis
many preparations of the abortus antigen have been made during the past seven
years by different methods, and in this paper techniques are described whereby
antigens capable of conferring a considerable degree of immunity to guinea-pigs
can be prepared.
For the isolation of the antigen it is unnecessary completely to disintegrate
the organisms, and for this and other reasons Miles and Pirie (1939c) suggested
that in Br. melitensis it might exist as a capsule. The same arrangement of the
antigen is probable in abortus organisms, and Huddleson (1940, 1941) has now
presented histological evidence for a capsule.
One strain of Br. abortus organisms has been used throughout this work. In
the earlier work on Br. melitensis (Miles and Pirie, 1939a, b, c) only one strain was
used. The differences in chemical and physical properties to be described may,
therefore, be strain and not species differences.
Preparation of the Antigen.
Suspensions were prepared in neutral 0 5 per cent phenol saline from 48-72
hours' liver agar growths of strain 544 (McEwen, Priestley and Paterson, 1939).
This strain is virulent, smooth, and requires 5-10 per cent C02 for good growth.
The cultures used as seed material were the second subcultures from a dried
culture (the fourth subculture of the original isolation on 26/3/36), except where
an early variant, able to grow without additional C02, was chosen for comparative
purposes.
Part of the antigen is extracted by the 0.5 per cent phenol, but this extract
contains the greater part of the agar breakdown products and other materials
that complicate the purification of the antigen. Unless economy of material is
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essential, therefore, it is better to centrifuge the suspension and discard the fluid,
or keep it for the preparation of largely disaggregated antigen by the methods
described later. The bacterial mass left after centrifuging is suspended in 20
times its weight of neutral 2 per cent phenol, and the' mixture is left, with occa-
sional shaking, for 1-2 weeks. After centrifuging for an hour at 3500 r.p.m. the
supernatant fluid is only slightly opalescent and contains most of the readily
extractable antigen; further similar extraction with 2 per cent phenol brings
out little more. There is no evidence that the use of stronger phenol increases
the yield.
The antigen can be isolated by the direct ultracentrifugation of this extract,
but this involves centrifuging inconveniently large volumes of fluid; it is, there-
fore, better to concentrate the extract first by ultrafiltration. " Cellophane "
sausage skin tube 2-2 in. in circumference is suitable if it is protected from hydro-
static stretching by being surrounded by a cloth tube of the same diameter. The
tube is knotted at one end, the other end tied firmly on to a rubber bung carrying
a filling tube, and the whole is mounted in a bottle that can be exhausted and
left clipped off. If the tube is kept filled and if its inside is at atmospheric pres-
sure while its outside is at about 20 mm. pressure, the initial rate of ultrafiltration
is about 1 ml. per hour per cm. length of tube. Slight clogging during filtration
reduces the rate of flow, but this can be partly restored by releasing the vacuum
and, with the tube full of fluid but flaccid, rubbing the two internal faces together
gently. The fluid is ready for ultracentrifugation when there is a significant
rise in its viscosity; at this stage it will have a solid content of 1 to 2 per cent.
The pH is adjusted to 7, and it is centrifuged for 30 min. at 10,000 r.p.m. to get
partial clearing.
An air driven ultracentrifuge of the type described by Masket (1941) was used
to sediment the antigen; in general the centrifuge runs lasted for 30 min. at 30,000
r.p.m. (R.C.F. 50,000). The supernatant fluid is poured off from the turbid
coherent pellets, and these are resuspended in water to give a fluid with a solid
content of less than 1 per cent and ultracentrifuged again. On a third similar
ultracentrifugation there is only a trace of unsedimented material in the super-
natant fluid; no further fractionation is therefore possible by ultracentrifuging
under these conditions. The pellets are resuspended in water, and cleared by
centrifuging for 30 min. at 10,000 r.p,m. It is the resulting colourless opalescent
fluid that is referred to as the antigen; solutions are stable at 00 C. for some
weeks, but after some months part of the material flocculates. Bacteria do not
grow in it readily, and it can be satisfactorily preserved with 0 5 per cent phenol.
Digestion with commercial trypsin or autoclaving liberates further quantities
of antigen from the bacterial mass left after extraction with 2 per cent phenol.
After 3-4 days' digestion at pH 8 and 40° C. in the presence of chloroform as
disinfectant the bacterial suspension is centrifuged and the antigen isolated by
differential centrifugation as before. The residue from this treatment is resus-
pended and is autoclaved for 15 min. at 1200 C. at an initial pH of 8-5. The pH
is of some importance, for it falls during autoclaving and the antigen is destroyed
below pH 6-5. If the suspension is made in 0-1 M phosphate buffer at 8-5 the
final pH will not be below 7-5. This extract also is worked up as before. These
two products should be kept separate from that made from the 2 per cent phenol
extract, for one of them may be contaminated with constituents of the com-
mercial trypsin, and the other is certainly contaminated with antigenically inert
fragments of the bacterium. The bacterial bodies are partly disintegrated by
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autoclaving, and if the fluid obtained by autoclaving a second time is fractionated
ultracentrifugally, a product with the physical properties associated with the
antigen can be separated. Its chemical properties are, however, clearly dis-
tinguishable from those of the antigen.
Batches vary somewhat both in the total yield of antigen and in the way in
which it is distributed between the different extracts. Good yields, expressed
as a percentpge of the dry matter of the bacterial sediment in the original 0 5
per cent phenol suspension are:
1 per cent from the 05 per cent phenol extract.
7 ,, ,, 2 per cent phenol extract.
2- 5 ,, ,, trypsin extract.
2- 5 ,, ,, extract on autoclaving.
Under the best conditions the yield of antigen may thus be 13 per cent of the
dry weight of the killed bacterium, and this yield is of the same order as that
found with Br. melitensis. Yields may, however, fall to half of these values.
CHEMICAL AND PHYSICAL PROPERTIES OF THE ANTIGEN.
In its purified form the antigen is soluble over the whole pH range, but it
readily precipitates from crude solutions along with any other material that is
acid precipitable. Unlike solutions of the Br. melitensis antigen this material
does not show anisotropy of flow. Solutions are apparently unaffected by heat-
ing for periods up to an hour at 1000 C. in the neutral range, and 60 per cent of a
preparation can be recovered by ultracentrifuging a solution that has been auto-
claved for an hour at 120° C. and pH 7.
Preparations made by the methods described are ultracentrifugally inhomo-
geneous, as would be expected if they consist of particles derived by the more
or less random fragmentation of a bacterial capsule. By centrifugation at an
intermediate speed, such as 20,000 r.p.m., some fractionation is possible. The
fractions do not differ from one another fundamentally in their chemical proper-
ties; their biological properties have not been compared.
After drying or freezing part of the antigen becomes insoluble, and all pro-
ducts that are to be used as immunizing agents or for serological studies have
therefore been kept in solution. The antigen, unlike most other large molecules,
cannot be satisfactorily dried by sublimation, for it forms a loose incoherent mass
that is scattered by the wind from the evaporating ice. Analytical and bio-
logical data depend on dry weights measured by evaporating samples of the
salt-free solution to dryness at room temperature over P205 in vacuo. Conditions
were such that the dried film was less than 0-1 mm. thick; drying is likely to have
been complete throughout, and frequent checks showed no further loss of weight
on drying at 1000 C. These films are hygroscopic, but do not pick up water with
the avidity of the more open textured mass that results from drying by sublima-
tion. About 5 per cent of water is absorbed by the time weighing is finished;
the results have not been corrected for this moisture content.
The nitrogen content is 4-5 per cent, but, as with other materials of this type,
it is not a trustworthy index of contamination, for the probable contaminants
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have similar nitrogen contents. Carbohydrate, estimated by an orcin method
(Pirie, 1936), using glucose as standard, falls in the range 10-12. per cent, but
the high lipid content makes this method somewhat uncertain on account of the
slight turbidity of the final coloured solution. The main value of the determina-
tion is to detect contamination with agar; this gives a cherry red colour in the
early stages of the estimation, and any preparation which gives this colour or
contains more than 13 per cent of carbohydrate can probably be further purified
by ultracentrifugation. The formyl content is a trustworthy index of the presence
of antigen, for formic acid is not known to be liberated, under the conditions
used, from any other substance except the melitensis antigen. 10-20 mg. lots
of antigen are hydrolysed for 30 min. at 1000 C. with 1-2 ml. of N H2SO4, and
formic acid is estimated (Pirie, 1946) on an aliquot of the hydrolysate. Agar
yields formic acid slowly when heated with acids, but the amounts that can
remain in a purified preparation of antigen introduce a negligible error if the
hydrolysis only lasts for 30 min. Values range from 4 to 5 per cent of CHO
Lower values are given by products made by autoclaving the bacterial residue
because these are contaminated with fragments of the bacterium; higher values
will be given by products from which the loosely bound phospholipid has been
partially removed.
The phosphorus content varies in the range 0 7 to 2-0 per cent. Most of the
phosphorus is present as phospholipid, and it can be separated from the antigen
by treating an aqueous solution with 10 volumes of a mixture of alcohol and
ether containing 0.5 per cent of concentrated hydrochloric acid (Miles and Pine,
1939a). The defatted residue is fairly constant in its properties. It is now only
partially soluble in water, and contains 0-5 per cent of phosphorus. Half of this
is liberated as phosphate after hydrolysis for an hour at 1000 C. in N/12 HCI;
the other half remains soluble after this treatment, but is present in the amor-
phous precipitate that separates on hydrolysis with stronger acid. This pre-
cipitate closely resembles the one prepared in the same way from the melitensis
antigen and called PL2 (Miles and Pirie, 1939c).
The variability of the phosphorus content of the antigen is due to variations
in the amount of phospholipid associated with it and in an extensive series of
analyses products with satisfactory centrifugal behaviour and formyl content
have always contained about 0 5 per cent of phosphorus not soluble in lipid
solvents. Products made from the 2 per cent phenol extract have a higher
phospholipid content than those made by the other three methods of extraction,
and the more rapidly sedimenting fraction of a preparation generally has a higher
phosphorus content than the more slowly sedimenting part. No sharp segre-
gation into fractions of different phospholipid content has, however, been possible.
Some of the nitrogen in the antigen occurs in these two phospholipid fractions,
but the greater part remains soluble after acid hydrolysis, and this solution gives
the Elson and Morgan (1933) colour reaction for amino-sugars. As with the
corresponding product from Br. meliten8i8 (Miles and Pirie, 1939d), the colour
reaction is given without preliminary acetylation; there is, therefore, reason
to think that the substance present is not one of the already known amino-
sugars.
In the course of preparation the antigen is only subjected to ultracentrifugal
fractionation, and this is designed to give a group of particles having sedimentation
constants within a fairly broad range. Other methods of fractionation which
might be of use both in the preparation and as criteria of homogeneity have
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therefore been sought, but so far without success. Precipitation with alcohol
or acetone removes part of the lipid and makes much of the antigen insoluble
in water. Precipitation with ammonium sulphate at 40 per cent of saturation
does not appear to alter the antigen if the precipitate is centrifuged off and re-
dissolved in water in a few minutes, but if contact with ammonium sulphate of
this concentration lasts for some hours much of the antigen is so altered as to
be no longer soluble in water. Solubility can be restored by washing the precipi-
tate free from ammonium sulphate and heating it in neutral aqueous suspension
at 1000 C. for some hours. Preparations that have been disaggregated by auto-
claving or treatment with organic solvents can also be partially reaggregated by
exposure to half saturated ammonium sulphate solution.
This behaviour with ammonium sulphate complicates the separation of the
small amount of antigen from the original 0 5 per cent phenol extract of the
bacteria. In a few experiments part of this extract has been directly ultra-
centrifuged, but the volume is too large for this to be a satisfactory routine pro-
cedure. Agar breakdown products in it precipitate with ammonium sulphate,
but this precipitate does not redissolve unless the ammonium sulphate concen-
tration is lowered below 1/1Oth of saturation. To separate the antigen, therefore,
360 g. of ammonium sulphate is added to each litre of extract; the precipitate
is centrifuged off immediately and suspended in 4-5 times its bulk of water.
After some hours it is centrifuged; the fluid contains much of the antigen, and
this can be recovered by dialysis and ultracentrifugation. Alternatively the
ammonium sulphate precipitate can be mixed with phenol or pyridine to dis-
aggregate and dissolve the antigen; from this solution it is precipitated by
alcohol, and can be purified by ultracentrifugation after partial aggregation with
ammonium sulphate. By these procedures it is possible to recover only about
half the antigen that can be separated by direct ultracentrifugation.
Disaggregation of the Antigen.
In some of the biological tests to be described later, disaggregated products
have been used. A brief account of the methods used in their preparation is
therefore necessary, but no conclusions about the nature of the differences between
fractions with different physical properties have yet been reached.
Many disaggregating agents have been tried, but only concentrated phenol,
pyridine and shaking with chloroform and amyl alcohol have been found to give
reproducible results. In each case the treatment results in the separation of the
antigen into two main fractions. The optically homogeneous solution that
results when an aqueous solution of antigen is mixed with six parts of phenol
or pyridine at room temperature gives a clear gelatinous layer when centrifuged
at 3000 r.p.m. Disaggregated antigen can be recovered from this gelatinous layer
by extraction with water, after removal of the reagent by washing with alcohol
on the centrifuge. Similarly, part of the antigen, disaggregated, is present in
the emulsion layer that is formed when the antigen, dissolved in acetate buffer
at pH4, is shaken with chloroform and amyl alcohol (Sevag, 1934). The material
soluble in phenol or pyridine can be precipitated by alcohol, and these precipitates
dissolve freely in water. All the solutions thus obtained are clearer than those
of the original antigen at the same concentration, and they are incompletely
sedimented even when centrifuged at 40,000 r.p.m. A few comparisons have
been made of the sedimentability of the original and disaggregated antigen at
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24,000 r.p.m. Whereas 80-90 per cent of the former sediments into a coherent
pellet in 30 min., only a third of the latter does so. There is no regular difference
between products disaggregated by the three different methods, nor between the
different fractions that result from each technique of disaggregation. In the
biological tests reported only that part of a disaggregated preparation that
sedimented at 24,000 r.p.m. was used.
Disaggregated antigen, from which the loosely bound phospholipid had been
separated, was easily made from the melitensis antigen by treatment with 80 per
cent acetic acid (Miles and Pirie, 1939a). This treatment is unsatisfactory with
the abortus antigen because it is not soluble in strong acetic acid, and, although
the treatment disaggregates part of the antigen, most of it is rendered insoluble
in water. Disaggregated melitensis antigen was polydisperse, but it behaved
towards precipitating agents like a single substance, and could be used as a con-
venient form of the antigen both in its isolation and in the study of many of its
biological properties. It is clear from this survey that no such method of con-
verting the abortus antigen into a water-soluble material of relatively low mole-
cular weight has as yet been found.
BIOLOGICAL PROPERTIES.
Inoculation of the Antigen into Normal Animals.
(a) Rabbits.-Intradermal inoculatioii of 0.1 to 1 mg. produced small hard
swellings at the site of inoculation at the 48th to 72nd hours. With certain
preparations there was very slight necrosis of the superficial dermis at the 72nd
hour, but all sites of injection had resolved by the 10th day without the skin
breaking. In many animals, although not constantly with any given dose, a
secondary oedematous inflammatory reaction was noted at the site of inoculation
about the 9th-llth day. These swellings resolved in from 7-10 days, and pre-
sumably were due to circulating antibodies reacting with residual traces of antigen
in the skin. Agglutinins were developed, reaching their maximum titre (1: 640-
1:1280) between the 6th and 11th days. By the 60th day they had dropped
to 1: 20-1 : 40. The inoculation of small single doses of the antigen by the intra-
muscular, intravenous or -subcutaneous route provoked similar agglutinin
responses.
The effect of repeated intradermal inoculation on the circulating agglutinins
has been studied. In the first experiment groups of two rabbits were given a
total dose of 0-6 mg. of the antigen as one, two and four doses at intervals of 28
days. Severe local reactions followed at the sites of the repeated inoculations.
Necrotic areas up to 2 cm. in diameter developed, which subsequently sloughed.
The titre continued to fall for four days after each repeat dose, and thereafter
rose to 1: 640 or 1: 1280 during the course of a further 6-11 days, after which
the titre again receded. Sixty days after the last portion of the total dose of
0-6 mg. had been inoculated the titres were at 1 : 20 to 1 : 40 level, at which
height they remained for a further 60 days, when observation ceased.
In the second experiment a rabbit was given four doses of 03 mg. at intervals
of 10-11 days. Three others were similarly inoculated with four doses of 0-03
mg., 0003 mg. and 0 0003 mg. respectively. Local reactions were noted follow-
ing the repetition of the 0-3 mg. doses, but not with those of smaller amount.
The 0 3 mg. doses (repeated) at 10-11 day intervals maintained the titre at an
almost constant level of 1 : 640-1: 1280 from 7 days after the first dose until
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10 days after the last. The rabbits inoculated with 0 03 mg. and 0 003 mg.
developed titres similarly, but at a lower level, viz. 1: 80-1 160. With 0 0003
mg. the titres failed to rise above 1: 40.
In a third experiment three rabbits were given five doses of 0 3, 0 03 mg. and
0 003 mg. respectively at 7-day intervals, and the same treatment was applied
to three rabbits at 3-day intervals.. The effect of repeating these inoculations
at short intervals was to increase agglutinin production slightly and to delay the
maximum until about the 12th day. The rabbits inoculated with 0 3 mg. at
3- and 7-day intervals had maximum titres of 1: 5000 on the 12th day after the
first inoculation. The titres receded to 1: 1280 by the 18th day. In the 3-day
interval rabblt this recession was continuous but slow. The titre of the 7-day
interval rabbit remained steady at 1: 1280 from the 18th to the 44th day and
then dropped slowly. At 85.days both rabbits had titres of 1: 160. The agglu-
tinin response in the rabbits inoculated with the smaller doses was in all respects
similar to the above but on a lower level: with 0 03 mg. the maximum titre
recorded was 1: 640, and with 0*003 mg. 1: 320 on the 10th and 12th days.
Residual titres on the 89th day were 1: 40-1: 80.
The inoculation of larger amounts of antigen (3-10 mg.) caused transient
inappetance and some loss of bodily condition for a few days. A large oedematous
and erythematous swelling up to 5 cm. in diameter developed within 24 hours,
and by the 72nd hour the centre of the swelling was necrotic (1 x 1 cm.) and
umbilicated. About the 8th-lOth day the necrotic centre sloughed away,
releasing a variable quantity of pus. Healing took 4-6 weeks.
Repeated intramuscular inoculation of small doses did not cause any observ-
able symptoms.
(b) Guinea-pigs.-Intradermal inoculation 0 1 to 1 mg. of antigen produced
an evanescent local reddening. Inoculation of 3 to 10 mg. caused a more severe
local reaction with necrosis, followed by rapid healing. In many animals secon-
dary reactions were noted, as in rabbits.
(c) Cattle.-Two normal yearling calves which were inoculated intradermally
with 1 mg. of antigen developed hard, non-painful swellings which disappeared
very slowly, some trace of them still being discernible after 6 weeks. The two
animals developed their maximum titre (1: 640) within 6 days after inoculation.
Sixty days after inoculation their titres were 1 : 40.
Inoculation into Sensitized Animals.
Small doses of antigenic fractions of varying molecular size have been inocu-
lated into rabbits and calves which had been sensitized 28 days earlier by sub-
cutaneous inoculation, with suitable doses of living Br. abortUs, for which purpose
a smooth aerobic strain of moderate virulence (McEwen, 161) was used. The
reactions of these sensitized animals were much more vigorous than those of
normal animals.
In rabbits local oedema and reddening was observed at the 24th hour, and by
the 72nd hour this had progressed so that a necrotic lesion approximately 1 cm.
across was seen. This was followed in 4-7 days by scab formation. Subsequent
healing was slow, taking 20-30 days, but there was no pus formation.
A series of nine sensitized and six normal control calves was inoculated intra-
dermally into the skin of the neck region. The technique used in these experi-
ments was essentially the same as that employed in carrying out the intradermal
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test with tuberculin, the increase in the thickness of a fold of skin at the point
of inoculation being determined by calipers. In the sensitized calves soft swell-
ings developed, which were oedematous and painful, but they did not become
necrotic. They reached their maxima at the 72nd hour, the skin thickness being
then increased up to 12 mm. with the most active preparations. Resolution was
slow, the skin not returning to normal for a period of 24-48 days. The swellings
which developed in the control animals were hard and circumscribed and reached
their maxima in 48 hours, fading greatly by the 72nd hour.
Immunization Experiments in Guinea-pigs.
Preliminary small scale experiments, that need not be reported in detail,
showed that fractions made from the bacteria by many different procedures did,
in varying degree, confer protection on guinea-pigs against subsequent paren-
teral infection with virulent organisms. These experiments also suggested that
the strain, age, sex and weight of the guinea-pig affected the protection. In the
experiments reported animals of the same strain and comparable age and weigh-
ing 300-400 g. were used. At the chosen interval after treatment with the sub-
stance under investigation, the group of animals was divided into three sub-
groups. Except in the experiment recorded in Table I these received, as test
dose intramuscularly in the thigh, 1 ml. of 1 in 10-5, 1 in 10-6, 1 in 10-7dilutions
respectively of a saline suspension of a 48-72-hour growth of strain 544 standar-
dized by opacity to tube 3 on Brown's scale. In the experiment shown in Table I
the doses were 1 ml. of 1 in 10-6, 1 in 10-7 and 1 in l0-8 dilutions. Immediately
before injecting the test doses, viable counts were made on blood agar plates or
by inoculating " roll " tubes made with liver agar. These counts showed that
the test doses contained approximately 40,000, 4000, 400 and 40 organisms.
TABLE I.
Product. Dose. Infection rate.
10-3 mg. of washed phenol killed bacteria . 10-6 1/10 10%)
10-7 5/10 50% 9/30 30%
10-8 3/10 30%)
0 3 mg. of a 2 per cent phenol extract pre- 10-6 1/10 10%)
cipitated by ammonium sulphate and frac- 10-7 3/10 30% F 4/30 13%
tionated by ultracentrifugation 10-8 0/10 .. )
0 3 mg. of a 2 per cent phenol extract frac- 10-6 2/9 22.2%)
tionated by ultracentrifugation 10-7 7/10 70% 10/28 35%
10-8 1/9 11.1%)
Controls . . . 10-6 10/10 100%)
10-7 10/10 100% 29/30 96.6%
10-8 9/10 90%)
Notes.-(1) In the above and in subsequent tables the denominator indicates the number of
animals exposed to infection and the numerator the number infected.
(2) The test doses are expressed as dilutions of a suspension standardized by opacity to correspond
with tube 3 on Brown's scale. The volume of the infecting suspensions employed was 1 c.c., the
10-6 dilution containing approximately 4000 viable organisms.
Six weeks after infection all the animals were killed, the blood agglutinin
titres determined, and the spleens ground up in 1 per cent broth-saline and cul-
tured for Br. abortUs. The presence of live organisms in the spleen has been
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accepted as evidence that any immunity engendered had been overcome. The
immunizing values of the various fractions or of different methods of immunization
have been assessed by a comparison of the infection rates.
In Table I two products are compared with a quantity of killed organisms
containing as much or more antigen; it is clear that the partially purified antigen
is as effective as the killed organisms. Two products, derived from the same
Product.
Aggregated,
3 mg. i.d.
Disaggregated,
1 mg. i.d.
Controls
Test dose.*
10-5
10-6
10-7
10-5
10-6
10-7
10-5
10-6
10-7
TABLE II.
Interval between test dose and
killing.
1 s
6 weeks.
2/4
2/4
0/4
3/4
3/4
3/4
6/6
6/6
5/6
9 weeks. 12 weeks.
0/1 .
1/4 . 0/1
1/4
2/2
3/4 . 1/1
1/1
6/6 . 6/6
6/6 . 6/6
6/6 . 6/6
-' Total infection rate.
6/22 27%
16/20 80%
53/54 98%
* The test dose was administered thirteen weeks after the vaccine dose.
Product. n
2 per cent phenol extract
precipitated with am-
monium sulphate and
redissolved by heating
Extract from bacterial
residue by trypsin di-
gestion and autoclav-
ing
Controls
Number of viable brucella in
1 c.c. of 10-6 dose
Dose in
rg. dry
matter.
0*3
i.d.
TABLE III.
Test Cambridge. Weybridge.dose.
10-5
10-6 .
10-7
8/9
8/10
3/10
0 3 . 10-5 . 7/10
i.d. . 10-6 . 5/10
10-7 . 0/8
.. . 10-5 .
..
. 10-6 .
.. . 10-7 .
10/10
10/10
9/10
. 8/12
5/14
1/13
7/12
2/14
1/13
. 12/12
. 12/12
. 12/12
Total infection rate.
16/21 76%
13/24 54% > 33/68 48%
4/23 17%
14/22 64%
7/24 29% t 22/67 33%
1/21 5% J
22/22 100%
22/22 100% . 65/66 98%
, 21/22 95% J
3700 . 4360
Note.-The products were prepared from strain 544A (aerobic).
batch of organisms, and which were fractionated by differential centrifugation
so as to yield an aggregated and a disaggregated fraction were compared and the
results are set out in Table II. It is clear that the former is the more effective.
The efficacy of antigens prepared from the 2 per cent phenol extract of the bac-
teria and from the bacterial residue after this extraction by digestion with trypsin
and autoclaving is shown in Table III to be comparable. These two products,
unlike all the others for which the results of tests are given here, were made from
a variant of strain 544 that did not need CO2.
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A product prepared by digestion with trypsin and autoclaving a suspension
of a CO2 culture of 544 was selected for an investigation into the effect of varying
the time interval between a single dose of the antigen and infection; of giving
two doses of antigen and of giving a single larger dose.
Treatment.
A
Single dose 8 weeks
before infection. 0 3
mg. in 0-2 c.c.
B
Single dose 4 weeks
before infection. 0 3
mg. in 0-2 c.c.
Single dose 2 weeks
before infection. 0 3
mg. in 0-2 c.c.
D
Two doses 6 and 2
weeks before infec-
tion, each of 0 3 mg.
in 0-2 c.c.
E
Single dose 2 weeks
before infection. 0-6
mgin 0-4 c.c.
Controls
Viable count of 1 ml.
of 10-6 dose
TABLE IV.
Test Cambridge. Weybridge.dose.eyrde
. 10-5 .
10-6
10-7
10-5
10-6
10-7
. 10-5
10-6
10-7
. 10-5 .
10-6
10-7
8/10
6/10
0/9
7/10
3/10
1/10
9/10
6/10
2/10
4/10
1/10
1/10
. 10-5 . 7/8
10-6 . 2/7
10-7 . 0/7
. 10-5
10-6
10-7
10/10
10/10
10/10
4/10
3/10
0/10
5/10
2/10
1/10.
7/10
2/10
1/10
. 3/10
. 0/10
. 1/10
9/10
4/10
1/10
10/10
10/10
10/10'
Total infection rate.
12/20 60%/
9/20 450/ 21/59 36%
0/19 0% J
12/20 60%°
5/20 25% .18/60 30%
1/20 5%/ J
16/20 80%°
8/20 40%° 27/60 45%
3/20 15%J
7/20 35%j1/20 5% t 10/60 17%
2/20 10%°J
16/18 89%°
6/17 35% S23/52 44%
1/17 6%°J
20/20 100%O
20/20 100% S60/60 100%
20/20 100%°J
. 4700 . 3970
Note.-The product used in this experiment was from C02-sensitive strain 544, and was made byincubating washed organisms with trypsin and autoclaving the residue.
The results of this experiment (Table IV) clearly indicated that the injection
of two doses spaced by a month was superior to any of the single injection methods,
and that probably the best time for a single injection was about four weeks
before injection of the test dose. There was no indication that doubling the dosehad any beneficial effect when given 14 days before infection. In a preliminary
experiment we found that increasing the dose five times (to 1V5 mg. i.d.) did not
give increased protection when the interval between vaccination and infection
was 28 days.
There was, however, one feature of this experiment which calls for mention.
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Earlier in this paper attention has been drawn to the severe reactions following
the intradermal inoculation of the antigen into sensitized rabbits and guinea-pigs.
One of the effects of the initial dose of 03 mg. in group D was to render a propor-
tion of the guinea-pigs sensitive, and the inoculation of the second dose was
followed by a marked local reaction. Twenty-four hours after inoculation the
site was hot, red and painful, and about 2 cm. in diameter. By the 72nd hour
it had enlarged to between 15 and 2-0 cm. The raised centre of the swelling
was yellow, becoming necrotic. By the fifth day the centre of the swelling was
purple, necrotic and definitely umbilicated. This necrotic tissue sloughed out.
Healing was fairly rapid, usually being complete by the 15th day.
A further experiment was carried out in which the antigen was a mixture of
aggregated products from several different lots of bacteria. Treatments B and
D of Table IV were repeated. In order to find out whether the local reaction
which follows a second injection could be avoided without reducing its effective-
ness, by using the intramuscular route, groups were set up in which the primary
doses were intradermal and subsequent doses intramuscular. It was also decided
to observe the effect of the larger dose when given at what we believed to be the
optimum time before infection, viz. one month. The effect of dividing this
larger dose into four equal parts was also studied.
The intramuscular injections were performed in one of the hind limbs, the
other being reserved for the inoculation of the test dose. The interval between
infection and killing was approximately 42 days.
The local reactions to the second inoculation in Group B were severe, but in
Groups E and F the local reactions to the second or subsequent inoculations were
less marked. Rarely was necrosis and sloughing noted, but soft, raised, reddened
swellings were always produced.
No apparent ill-effects followed the intramuscular inoculations.
The results, which are set out in Table V, showed again that there was an
advantage in dividing the immunizing dose into two injections at an interval of
28 days, the last two weeks before test inoculation, but that the division of the
immunizing dose into four parts had no particular advantage over two. The use
of the intramuscular route for doses other than the first did not reduce the level
of protection. The inoculation of 06 mg. had no advantage over 03 mg. when
given as a single dose 28 days before infection.
DISCUSSION.
'The studies of Miles and Pirie (1939a, b, c) and the work presented here show
that Br. melitensis and Br. abortus contain antigens of a broadly similar nature
which can be separated from the bacterial cell in relatively pure states. They
have well defined physical and chemical characteristics, which can be used as
criteria in estimating their probable value as immunizing agents.
Brucella extracts have been used by various workers. A trichloracetic acid
extract prepared by Boivin's method from Br. melitensis was used by Roman
(1938), who claimed some immunizing properties. The antigen was said to be
non-protein in character and was called a glucolipid antigen. Priestley (1940)
and Stahl and Hamann (1941), however, were unable to protect guinea-pigs with
trichloracetic extracts of Br. abortus. Priestley's extract was antigenic, heat-
stable and slightly toxic, but it failed to elicit skin reactions in infected guinea-
pigs. He was also unable to obtain an antigen in this way from rough strains.
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Treatment.
A
Single dose 0 3 mg.
i.d. 4 weeks before
infection
B
Two doses 0 3 mg. i.d.
6 and 2 weeks before
infection
TABLE V.
doset Cambridge. Weybridge.
. 10-5
10-6
10-7
8/8
4/10
0/8
. 10-5 . 7/9
10-6 . 8/10
10-7 . 0/7
9/10
5/10
4/10
7/9
2/10
0/10
Total infection rate.
17/18 94%O
9/20 45%( .30/56 54%
4/18 22%J
14/18 78%
10/20 500%( 24/55 44%
0/17 0% J
C
One dose 0-6 mg. i.d.
4 weeks before in-
fection
. 10-5 .
10-6
10-7
7/7
7/10
4/10
9/10
5/10
2/10
16/17 94°/%
12/20 60% .34/57 60%
6/20 30%,J
D
0-3 mg. i.d. 6 weeks
before and 0-3 mg.
i.m. 2 weeks before
infection
E
4 doses each of 0-15
mg. i.d. given 14, 10,
6 and 2 weeks before
infection
F
2 doses 0-15 mg. i.d.
14 and 10 weeks
before infection fol-
lowed by 2 doses
0 15 mg. i.m. 6 and
2 weeks before in-
fection
Controls
Viable count of 1 ml.
10-6 dose
. 10-5 .
10-6
10-7
8/9 . 1/10
6/10 . 1/10
3/10 . 1/10
10-5 . 7/9
10-6 . 6/10
10-7 . 2/9
10-5 . 6/9
10-6 . 5/9
10-7 . 0/9
10-5 . 7/7
10-6. 9/9
10-7 . 9/10
4120
5/10
0/10
1/9
4/10
4/10
2/9
9/10
. 10/10
8/10
5300
9/19 47%O
7/20 35%° 20/59 34%
4/20 20%J
12/19 63%
6/20 30%° 21/57 37%
3/18 17%J
10/19 53% )
9/19 47% S21/56 38%2/18 11%°J
16/17 94%
19/19100%° 52/56 93%
17/20 85%°J
Note.-The product used in this experiment was
several lots of bacteria (C02-sensitive).
a mixture of still aggregated extracts from
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Huddleson (1943) reported moderate protection of guinea-pigs by means of an
extract obtained by passing Br. abortus through a wet bacterial mill. The extract
was extremely unstable, its immunizing capacity being destroyed by 560 C. or
05 per cent phenol, and it seems unlikely therefore that the active constituent
is related to the material we find effective. Protection of guinea-pigs with an
extract was also reported by Live, Sperling and Stubbs (1945) using a sonic
method, which is believed not to denature labile somatic antigens (Chambers
and Flosdorf, 1936). They describe their product as containing protein. There
is reason to think that it may contain material resembling the antigen described
by us.
In our preliminary experiments on iummnization, fractions which had been
disaggregated by exposure to phenol or pyridine did not induce such a high degree
of resistance as those which were still in the aggregated state. Our observations
on the skin reactions in sensitized animals, on the other hand, showed that the
largest swellings were provoked by the disaggregated products. It would appear,
therefore, that there are different optimal particle sizes for skin testing and
immunization. It is also clear that an intracutaneous method for the detection
of sensitized cattle might be elabbrated. It would be of practical value only if
the skin reaction can be elicited by material so far disaggregated that it no longer
leads to the development of agglutinins in normal animals.
Having shown in the earlier experiments that particle size was of importance,
and having tested products prepared in a variety of ways, but all of which were
thought likely to have good immunizing properties (Tables I, II and III), atten-
tion was next directed to mode of administration and dosage. The finding
(Tables IV and V) that division of the inoculum into two injections with an interval
between was better than increase of the size of a single dose was not unexpected.
Further division (Table V) appears of no advantage.
The variation found in successive experiments with products thought likely
to have similar protective properties was often greater than expected. There is
no doubt, however, that the fractions prepared have, taken as a whole, consider-
able protective properties. This is shown not only by the figures for positive
and negative post-mortem findings recorded here, but also by the less severe
infection and the marked reduction in the numbers of organisms recovered in
spleen counts from vaccinated animals as compared with the unvaccinated
controls.
The degree of protection is best expressed by comparison with other well-
known immunizing agents, such as the American Strain 19, now in general use
in the U.S.A. and Great Britain. It is now well established (Weybridge results,
unpublished) that living vaccines prepared with S. 19, which confer a high resist-
ance on cattle, fail to protect approximately 15, 20 and 50 per cent of guinea-
pigs respectively against the three test doses generally used in the work reported
here (i.e. except in the experiment in Table I). de Ropp (1945) has already
published somewhat similar results using the same methods. Comparison of the
results obtained with our fractions shows that the level of protection was some-
times similar to, or once (with two doses), greater than that conferred by S. 19,
but that with single doses it was usually definitely lower.
The relative values of antigens prepared from C02-sensitive and aerobic
strains have not been adequately investigated, but such evidence as we have
does not indicate that the former are greatly superior.
Such questions as the duration of immunity and the possibility of combining
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the antigen with living (avirulent) vaccine have not yet been considered, and
further work is needed on particle size, but we feel that the evidence that has been
accumulated regarding these antigens should be presented at this stage.
SUMMARY.
The methods employed to isolate an antigenic substance from suspensions
of Br. abortus are described together with its physical and chemical properties.
The inoculation of the antigen by various routes, in doses as low as 0 0003 mg.,
into normal animals causes the production of circulating agglutinins. When
large doses are inoculated intradermally symptoms oftoxaemia develop in addition
to massive local necrosis at the site of inoculation.
The intradermal inoculation of small doses of antigen into sensitized. animals
is marked by local oedema and swellings which tend to persist for lengthy periods.
As judged by guinea-pig tests, the antigen possesses considerable immunizing
powers. The resistance conferred by a single dose of 0 3 mg., or by larger doses,
was however usually lower than that produced by one dose of living Br. abortUw
of low virulence, e.g. S. 19. The results with'two doses of 0-3 mg. or with four
doses of 0- 15 mg. varied, but more nearly approached those obtained with strain 19.
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and Mr. K. C. Sellers (Cambridge) and Mr. R. S. de Ropp (Compton) for their
collaboration in various experiments, and Messrs. G. Salt and C. Williams (Wey-
bridge) for their technical assistance.
The studies here reported were carried out under the co-ordination of the
Agricultural Research Council's Brucella Conference. The Council granted funds
to the Institute of Animal Pathology, Cambridge, in aid of the investigation.
REFERENCES.
CHAMBERS, L. A., AND FLOSDORF, E. W.-(1936) J. biol. Chem., 114, 75.
DE RoPP, R. S.-(1945) J. comp. Path., 55, 70.
ELSON, L. A., AND MORGAN, W. T. J.-(1933) Biochem. J., 27, 1824;
HUDDLESON, I. F.-(1940) J. Amer. vet. med. Ass., 96, 708.-(1941) Bull. Mich. agric.
exp. sta., 177, 1l.-(1943) Ibid., 182, 45.
LIvE, I., SPERIRNG, F. G., AND STUBBS, E. L.-(1945) J. infect. Dis., 77, 16.
MCEWEN, A. D., PRIESTLEY, F. W., AND PATERSON, J. D.-(1939) J. comp. Path., 52,
116.
MASKET, A. V.-(1941) Rev. sci. Instrum., 12, 277.
MILES, A. A., AND PRE, N. W. (1939a) Brit. J. exp. Path., 20, 83.-(1939b) Ibid., 20,
109.-(1939c) Ibid., 20, 278.-(1939d) Biochem. J., 33, 1716.
PnRE, N: W.-(1936) Brit. J. exp. Path., 17, 269.-(1946) Biochem. J., 40, 100.
PRIESTLEY, F. W.-(1940) Vet. Rec., 52, 699.
ROMAN, G.-(1938) Thee medic. (Montpellier.)
SEVAG, M. G.-(1934) Biochem. Z., 273, 419.
STAHL, W. H., AND HAmANw, E. E.-(1941) Bull. Mich. agric. exp. Sta., 177, 19.
